UBS Group AG - ONCOBIOLOGICS INC ownership

ONCOBIOLOGICS INC's ticker is ONS and the CUSIP is 68235M105. A total of 16 filers reported holding ONCOBIOLOGICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ONCOBIOLOGICS INC
ValueSharesWeighting
Q3 2018$7,000
-12.5%
8,086
-19.8%
0.00%
Q2 2018$8,000
-20.0%
10,086
-13.3%
0.00%
Q1 2018$10,000
+11.1%
11,639
+70.2%
0.00%
Q4 2017$9,000
+125.0%
6,839
+186.3%
0.00%
Q3 2017$4,000
+100.0%
2,389
+22.5%
0.00%
Q2 2017$2,000
-60.0%
1,9500.0%0.00%
Q1 2017$5,000
-44.4%
1,950
-33.7%
0.00%
Q4 2016$9,000
+12.5%
2,943
+44.5%
0.00%
Q3 2016$8,000
+60.0%
2,036
+35.7%
0.00%
Q2 2016$5,0001,5000.00%
Other shareholders
ONCOBIOLOGICS INC shareholders Q1 2017
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 4,216,498$3,752,0000.22%
Avoro Capital Advisors LLC 683,531$608,0000.03%
ACUTA CAPITAL PARTNERS, LLC 29,082$26,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 138,000$123,0000.00%
Marshall Wace North America L.P. 261,800$233,0000.00%
Advisory Services Network, LLC 2,000$2,0000.00%
BANK OF AMERICA CORP /DE/ 10,000$9,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 11,165$9,0000.00%
VANGUARD GROUP INC 312,707$278,0000.00%
PANAGORA ASSET MANAGEMENT INC 57,162$51,0000.00%
View complete list of ONCOBIOLOGICS INC shareholders